Evogene (EVGN) Tops Q3 EPS by 8c

Evogene (NASDAQ: EVGN) reported Q3 EPS of ($0.08), $0.08 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $3.77 million versus the consensus estimate of $1.2 million.

For earnings history and earnings-related data on Evogene (EVGN) click here.

You May Also Be Interested In

• Evogene Chairman Nir Nimrodi to Join Quarterly Results Call to Address Current Dissident Shareholders Situation
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c